SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $93 million in its fourth quarter.

The Salt Lake City-based company said it had a loss of 40 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.

The biotechnology company posted revenue of $10.9 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $12.4 million.

For the year, the company reported a loss of $328.1 million, or $1.58 per share. Revenue was reported as $44.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News